Scott Biller
Directeur/Membre du Conseil chez FOGHORN THERAPEUTICS INC.
Fortune : - $ au 30/04/2024
Postes actifs de Scott Biller
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| FOGHORN THERAPEUTICS INC. | Directeur/Membre du Conseil | 09/01/2020 | - |
| Independent Dir/Board Member | 09/01/2020 | - | |
Remix Therapeutics, Inc.
 Remix Therapeutics, Inc. BiotechnologyHealth Technology Remix Therapeutics, Inc. operates as a biotechnology company. It involves in developing small molecule therapies which are designed to reprogram RNA processing to address the underlying drivers of disease. The company was founded by Pete Smith and is headquartered in Cambridge, MA. | Directeur/Membre du Conseil | 01/06/2020 | - |
Rome Therapeutics, Inc.
 Rome Therapeutics, Inc. BiotechnologyHealth Technology Rome Therapeutics, Inc. develops novel therapies for cancer and autoimmune diseases by harnessing the power of the repeatome-vast stretches of uncharted genetic materials. The company was founded by Rosana Kapeller and is headquartered in Cambridge, MA. | Directeur/Membre du Conseil | 01/02/2021 | - |
Historique de carrière de Scott Biller
Anciens postes connus de Scott Biller
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| AGIOS PHARMACEUTICALS, INC. | Directeur Technique/Scientifique/R&D | 01/09/2010 | 31/12/2019 |
Novartis Institutes for Biomedical Research, Inc.
 Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01/01/2003 | 01/09/2010 |
| Bristol-Myers Squibb Pharmaceutical Research Institute | Corporate Officer/Principal | 01/06/2001 | 01/07/2003 |
Formation de Scott Biller
| Massachusetts Institute of Technology | Undergraduate Degree |
| California Institute of Technology | Doctorate Degree |
Statistiques
Internationale
| Etats-Unis | 9 |
Opérationnelle
| Director/Board Member | 3 |
| Corporate Officer/Principal | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
Sectorielle
| Health Technology | 5 |
| Finance | 2 |
| Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| AGIOS PHARMACEUTICALS, INC. | Health Technology |
| FOGHORN THERAPEUTICS INC. | Health Technology |
| Entreprise privées | 4 |
|---|---|
Novartis Institutes for Biomedical Research, Inc.
Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA. | Commercial Services |
| Bristol-Myers Squibb Pharmaceutical Research Institute | |
Remix Therapeutics, Inc.
Remix Therapeutics, Inc. BiotechnologyHealth Technology Remix Therapeutics, Inc. operates as a biotechnology company. It involves in developing small molecule therapies which are designed to reprogram RNA processing to address the underlying drivers of disease. The company was founded by Pete Smith and is headquartered in Cambridge, MA. | Health Technology |
Rome Therapeutics, Inc.
Rome Therapeutics, Inc. BiotechnologyHealth Technology Rome Therapeutics, Inc. develops novel therapies for cancer and autoimmune diseases by harnessing the power of the repeatome-vast stretches of uncharted genetic materials. The company was founded by Rosana Kapeller and is headquartered in Cambridge, MA. | Health Technology |
- Bourse
- Insiders
- Scott Biller
- Expérience